Section one: Contracting authority/entity
one.1) Name and addresses
Ministry of Defence, Defence Science and Technology Laboratory
Porton Down
Salisbury, Wiltshire
SP4 0JQ
Country
United Kingdom
Region code
UK - United Kingdom
Internet address(es)
Main address
Buyer's address
one.4) Type of the contracting authority
Ministry or any other national or federal authority
one.5) Main activity
Defence
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Development and Manufacture of HI-6 Powder for Solution
two.1.2) Main CPV code
- 73100000 - Research and experimental development services
two.1.3) Type of contract
Services
two.1.4) Short description
The Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence, intends to award a Single Source Non-Qualifying Defence Contract valued at up to £1,200,000 (EX VAT) with Evonik Corporation of 299 Jefferson Rd, Parsippany, New Jersey, 07054-2827, United States (“the Contractor”) for the development, scale-up, clinical trial and manufacture of HI-6 DMS powder for solution product. The Contractor will provide manufacturing studies necessary for all stages of product development. The Authority will provide the Active Pharmaceutical to the supplier for all activities.
In accordance with regulation 4 of The Defence and Security Public Contracts (Amendment) (EU Exit) Regulations 2019 (SI No.2019/697) this procurement falls to be regulated under the provisions of the Defence and Security Public Contracts Regulations 2011 (DSPCR 2011) as amended (in particular by SI 2019/697 and SI 2020/1450). Prior publication of a contract notice in the Official Journal of the European Union is no longer appropriate. It is considered that this Contract can be placed, using the Negotiated Procedure Without Prior Publication of a Contract Notice pursuant in the UK e-notification service (as required by the relevant legislation) and is lawful in accordance with Regulation 16(1)(a)(i) of the DSPCR 2011 on the basis that the Contractor is the sole applicant to contract notice reference: 030221-2022 as amended by Notice reference 030278-2022.
two.1.6) Information about lots
This contract is divided into lots: No
two.1.7) Total value of the procurement (excluding VAT)
Value excluding VAT: £1,200,000
two.2) Description
two.2.2) Additional CPV code(s)
- 33661700 - Other nervous system medicinal products
- 33690000 - Various medicinal products
- 73300000 - Design and execution of research and development
two.2.3) Place of performance
NUTS codes
- UK - United Kingdom
two.2.4) Description of the procurement
The Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence, intends to award a Single Source Non-Qualifying Defence Contract valued at up to £1,200,000 (EX VAT) with Evonik Corporation of 299 Jefferson Rd, Parsippany, New Jersey, 07054-2827, United States (“the Contractor”) for the development, scale-up, clinical trial and manufacture of HI-6 DMS powder for solution product. The Contractor will provide manufacturing studies necessary for all stages of product development. The Authority will provide the Active Pharmaceutical to the supplier for all activities.
In accordance with regulation 4 of The Defence and Security Public Contracts (Amendment) (EU Exit) Regulations 2019 (SI No.2019/697) this procurement falls to be regulated under the provisions of the Defence and Security Public Contracts Regulations 2011 (DSPCR 2011) as amended (in particular by SI 2019/697 and SI 2020/1450). Prior publication of a contract notice in the Official Journal of the European Union is no longer appropriate. It is considered that this Contract can be placed, using the Negotiated Procedure Without Prior Publication of a Contract Notice pursuant in the UK e-notification service (as required by the relevant legislation) and is lawful in accordance with Regulation 16(1)(a)(i) of the DSPCR 2011 on the basis that the Contractor is the sole applicant to contract notice reference: 030221-2022 as amended by Notice reference 030278-2022.
two.2.5) Award criteria
Criterion: Technical (Including Social Value) Pass/Fail
Criterion: Price Pass/Fail
two.2.11) Information about options
Options: No
two.2.13) Information about European Union Funds
The procurement is related to a project and/or programme financed by European Union funds: No
Section four. Procedure
four.1) Description
four.1.1) Type of procedure
Negotiated procedure without publication of a contract notice
- No tenders or no suitable tenders/requests to participate in response to negotiated procedure with prior publication of a contract notice
- The products involved are manufactured purely for the purpose of research, experiment, study or development
Explanation:
The Defence Science and Technology Laboratory (Dstl), part of the UK Ministry of Defence, intends to award a Single Source Non-Qualifying Defence Contract valued at up to £1,200,000 (EX VAT) with Evonik Corporation of 299 Jefferson Rd, Parsippany, New Jersey, 07054-2827, United States (“the Contractor”) for the development, scale-up, clinical trial and manufacture of HI-6 DMS powder for solution product. The Contractor will provide manufacturing studies necessary for all stages of product development. The Authority will provide the Active Pharmaceutical to the supplier for all activities.
In accordance with regulation 4 of The Defence and Security Public Contracts (Amendment) (EU Exit) Regulations 2019 (SI No.2019/697) this procurement falls to be regulated under the provisions of the Defence and Security Public Contracts Regulations 2011 (DSPCR 2011) as amended (in particular by SI 2019/697 and SI 2020/1450). Prior publication of a contract notice in the Official Journal of the European Union is no longer appropriate. It is considered that this Contract can be placed, using the Negotiated Procedure Without Prior Publication of a Contract Notice pursuant in the UK e-notification service (as required by the relevant legislation) and is lawful in accordance with Regulation 16(1)(a)(i) of the DSPCR 2011 on the basis that the Contractor is the sole applicant to contract notice reference: 030221-2022 as amended by Notice reference 030278-2022.
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes
Section five. Award of contract/concession
Title
Powder For Solution (PFS)
A contract/lot is awarded: Yes
five.2) Award of contract/concession
five.2.1) Date of conclusion of the contract
17 March 2023
five.2.2) Information about tenders
The contract has been awarded to a group of economic operators: No
five.2.3) Name and address of the contractor/concessionaire
Evonik Corporation
299 Jefferson Road, New Jersey
Parsippany
07054-2827
Country
United States
NUTS code
- US - United States
The contractor/concessionaire is an SME
No
five.2.4) Information on value of contract/lot/concession (excluding VAT)
Initial estimated total value of the contract/lot/concession: £1,200,000
Total value of the contract/lot/concession: £1,200,000
five.2.5) Information about subcontracting
The contract/lot/concession is likely to be subcontracted
Section six. Complementary information
six.3) Additional information
This notice is not a request for expressions of interest so please do not apply to be invited to tender. This notice advises that the Authority has decided to negotiate a contract with the named supplier on a single source basis, and is published for reasons of transparency. If you are interested in becoming a sub-contractor for this requirement, you should apply directly to the supplier named above.
six.4) Procedures for review
six.4.1) Review body
Defence Science and Technology Laboratory
Porton Down
Salisbury
SP4 0JQ
Country
United Kingdom
six.4.2) Body responsible for mediation procedures
Defence Science and Technology Laboratory
Porton Down
Salisbury, Wiltshire
SP4 0JQ
Country
United Kingdom